AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2021
Apr 6, 2021
35221_dirs_2021-04-05_61b441be-c377-4873-87b6-bc9d67b1d6c0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2021-04-01
Reporting Person: MCGRATH DENNIS M (President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-01 | Common Stock | A | 150000 | — | Acquired | 955462 | Direct |
Footnotes
F1: The issuer granted 150,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
F2: Includes an aggregate of 26,462 shares of common stock purchased pursuant to the issuer's employee stock purchase program.
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23